Bayer sponsors Prostate Cancer Awareness Month efforts
WHIPPANY, N.J. — Bayer HealthCare on Thursday announced that it will sponsor community awareness efforts nationwide this September, in honor of Prostate Cancer Awareness Month.
Bayer will expand its educational initiative, Men Who Speak Up, to inform the public about one of the leading causes of cancer death among American men.
"Bayer is committed to supporting prostate cancer awareness and advocacy activities because we know the devastating impact this disease can have on people's lives," Dr. Joseph Germino, Bayer's VP for medical affairs in oncology, said. "For men with advanced prostate cancer, our global survey revealed they aren't speaking up about the warning signs of progressing disease."
Bayer also revealed an updated website (LINK www.MenWhoSpeakUp.com) that features data from the International Prostate Cancer Symptoms Survey and provides educational materials, including a doctor discussion guide and a symptom tracker tool.
The company will sponsor events nationwide throughout September, including educational sessions, conferences, awareness walks and runs for patients and the community. Some of these events include:
Prostate Cancer Research Institute's Prostate Cancer Conference (Sept. 11 to 13), an annual patient event held in Los Angeles that provides a weekend of educational sessions on the latest treatment options, lifestyle changes and quality of life issues;
UsToo's 11th Annual SEA Blue Prostate Cancer Walk & Run (Sept. 13), education sessions and free PSA testing in Lincoln Park in downtown Chicago;
Prostate Health Education Network's Virtual Prostate Cancer Walk (runs through Sept. 18), an online effort to increase awareness about current pressing prostate cancer issues, including early detection, patient care, research and education; and
ZERO Prostate Cancer Run/Walks (occurring between Aug. 30 to Nov. 21), an annual run/walk series taking place in more than 40 cities across the country as part of the group's effort to make prostate cancer a national priority.
In late September, Bayer will analyze data from a survey of more than 1,200 people affected by advanced prostate cancer from across 10 countries. The results will be released at the 2015 European Cancer Congress in Vienna, Austria on Sept. 25.